Sign in

CIK 0000320017 · Non-accelerated filer<br>Smaller reporting company

LISATA THERAPEUTICS, INC.

Sign in to watch
Ticker
LSTA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
222343568
Phone
908-229-2590
Business address
110 ALLEN ROAD, SECOND FLOOR, BASKING RIDGE, NJ, 07920
Former names
Caladrius Biosciences, Inc., CALADRIUS BIOSCIENCES, INC., NeoStem, Inc., PHASE III MEDICAL INC/DE, CORNICHE GROUP INC /DE
  1. 4 Grant or award Director acquired 20,000 shares (grant or award)
  2. 4 Grant or award Director acquired 20,000 shares (grant or award)
  3. 4 Shares withheld for taxes President & CBO gave up 3,358 shares (to pay taxes)
  4. 4 Shares withheld for taxes Chief Executive Officer gave up 11,315 shares (to pay taxes)
  5. 4 Shares withheld for taxes EVP, R&D and CMO gave up 2,659 shares (to pay taxes)
  6. 3 Insider Initial Statement of Ownership
  7. 3 Insider Initial Statement of Ownership
  8. 3 Insider Initial Statement of Ownership
  9. 4 Grant or award Director acquired 19,200 shares (grant or award)
  10. 3 Insider Initial Statement of Ownership
  11. 4 Shares withheld for taxes EVP, R&D and CMO gave up 69,959 shares (to pay taxes)
  12. 4 Grant or award Chief Executive Officer acquired 150,000 shares (grant or award)
  13. 4 Shares withheld for taxes Chief Executive Officer gave up 13,082 shares (to pay taxes)
  14. 4 Shares withheld for taxes CLO, SVP of Corp Dev gave up 4,721 shares (to pay taxes)
  15. 4 Shares withheld for taxes Chief Executive Officer gave up 73,150 shares (to pay taxes)
  16. 4 Shares withheld for taxes CLO, SVP of Corp Dev gave up 22,127 shares (to pay taxes)
  17. 4 Shares withheld for taxes EVP, R&D and CMO gave up 7,694 shares (to pay taxes)
  18. 4 Grant or award Director acquired 65,430 shares (grant or award)
  19. 4 Grant or award Director acquired 65,430 shares (grant or award)
  20. 4 Grant or award Director acquired 65,430 shares (grant or award)

Page 3 of 33 · 648 filings